215 related articles for article (PubMed ID: 19339987)
1. Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus.
Kariuki SN; Moore JG; Kirou KA; Crow MK; Utset TO; Niewold TB
Genes Immun; 2009 Jul; 10(5):487-94. PubMed ID: 19339987
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin and interleukin-17A genes polymorphisms in Egyptian systemic lupus erythematosus patients: A relation to disease activity and severity.
Pasha HF; Tantawy EA; Youssef MA
Gene; 2019 Jun; 702():107-113. PubMed ID: 30898714
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus.
Trivedi T; Franek BS; Green SL; Kariuki SN; Kumabe M; Mikolaitis RA; Jolly M; Utset TO; Niewold TB
J Biomed Biotechnol; 2011; 2011():802581. PubMed ID: 22131818
[TBL] [Abstract][Full Text] [Related]
4. Correlation between circulating osteopontin level in systemic lupus erythematosus and disease activity and associations between osteopontin polymorphisms and disease susceptibility: A meta-analysis.
Lee YH; Song GG
Lupus; 2017 Feb; 26(2):132-138. PubMed ID: 27307447
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
Wirestam L; Enocsson H; Skogh T; Padyukov L; Jönsen A; Urowitz MB; Gladman DD; Romero-Diaz J; Bae SC; Fortin PR; Sanchez-Guerrero J; Clarke AE; Bernatsky S; Gordon C; Hanly JG; Wallace D; Isenberg DA; Rahman A; Merrill J; Ginzler E; Alarcón GS; Chatham WW; Petri M; Khamashta M; Aranow C; Mackay M; Dooley MA; Manzi S; Ramsey-Goldman R; Nived O; Steinsson K; Zoma A; Ruiz-Irastorza G; Lim S; Kalunian K; Inanc M; van Vollenhoven R; Ramos-Casals M; Kamen DL; Jacobsen S; Peschken C; Askanase A; Stoll T; Bruce IN; Wetterö J; Sjöwall C
J Rheumatol; 2019 May; 46(5):492-500. PubMed ID: 30647177
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin gene polymorphism in association with systemic lupus erythematosus in Chinese patients.
Xu AP; Bai J; Lü J; Liang YY; Li JG; Lai DY; Wan X; Huang HH
Chin Med J (Engl); 2007 Dec; 120(23):2124-8. PubMed ID: 18167187
[TBL] [Abstract][Full Text] [Related]
7. Role of osteopontin in systemic lupus erythematosus.
Kaleta B
Arch Immunol Ther Exp (Warsz); 2014 Dec; 62(6):475-82. PubMed ID: 24917428
[TBL] [Abstract][Full Text] [Related]
8. Association of the rs1126616 and rs9138 Variants in the
Rivera-Cameras A; Gallegos-Arreola MP; Morán-Moguel MC; Salazar-Páramo M; Alcaraz-López MF; Echeverría-González G; Topete-Reyes JF; Franco-Chávez SA; Dávalos-Rodríguez IP
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256074
[TBL] [Abstract][Full Text] [Related]
9. Associations Between
Lee YH; Song GG
Genet Test Mol Biomarkers; 2023 Sep; 27(9):277-283. PubMed ID: 37695811
[No Abstract] [Full Text] [Related]
10. Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus.
D'Alfonso S; Barizzone N; Giordano M; Chiocchetti A; Magnani C; Castelli L; Indelicato M; Giacopelli F; Marchini M; Scorza R; Danieli MG; Cappelli M; Migliaresi S; Bigliardo B; Sabbadini MG; Baldissera E; Galeazzi M; Sebastiani GD; Minisola G; Ravazzolo R; Dianzani U; Momigliano-Richiardi P
Arthritis Rheum; 2005 Feb; 52(2):539-47. PubMed ID: 15692970
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients.
Salloum R; Franek BS; Kariuki SN; Rhee L; Mikolaitis RA; Jolly M; Utset TO; Niewold TB
Arthritis Rheum; 2010 Feb; 62(2):553-61. PubMed ID: 20112359
[TBL] [Abstract][Full Text] [Related]
12. Serum osteopontin negatively impacts on intima-media thickness in patients with systemic lupus erythematosus.
Carbone F; Dallegri F; Montecucco F; Poggi A; Nobili FM; Cacciapaglia F; Afeltra A; Moccetti T; Colombo BM
Eur J Clin Invest; 2019 May; 49(5):e13089. PubMed ID: 30767212
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin and systemic lupus erythematosus association: a probable gene-gender interaction.
Han S; Guthridge JM; Harley IT; Sestak AL; Kim-Howard X; Kaufman KM; Namjou B; Deshmukh H; Bruner G; Espinoza LR; Gilkeson GS; Harley JB; James JA; Nath SK
PLoS One; 2008 Mar; 3(3):e0001757. PubMed ID: 18335026
[TBL] [Abstract][Full Text] [Related]
14. Interferon regulatory factor 3 as key element of the interferon signature in plasmacytoid dendritic cells from systemic lupus erythematosus patients: novel genetic associations in the Mexican mestizo population.
Santana-de Anda K; Gómez-Martín D; Monsivais-Urenda AE; Salgado-Bustamante M; González-Amaro R; Alcocer-Varela J
Clin Exp Immunol; 2014 Dec; 178(3):428-37. PubMed ID: 25130328
[TBL] [Abstract][Full Text] [Related]
15. Association of the osteopontin rs1126616 polymorphism and a higher serum osteopontin level with lupus nephritis.
Salimi S; Noora M; Nabizadeh S; Rezaei M; Shahraki H; Milad MK; Naghavi A; Farajian-Mashhadi F; Zakeri Z; Sandoughi M
Biomed Rep; 2016 Mar; 4(3):355-360. PubMed ID: 26998275
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum osteopontin level and gene polymorphism as biomarkers: analyses from the Nordic Adjuvant Interferon alpha Melanoma trial.
Prasmickaite L; Berge G; Bettum IJ; Aamdal S; Hansson J; Bastholt L; Øijordsbakken M; Boye K; Mælandsmo GM
Cancer Immunol Immunother; 2015 Jun; 64(6):769-76. PubMed ID: 25832001
[TBL] [Abstract][Full Text] [Related]
17. Association of osteopontin regulatory polymorphisms with systemic sclerosis.
Barizzone N; Marchini M; Cappiello F; Chiocchetti A; Orilieri E; Ferrante D; Corrado L; Mellone S; Scorza R; Dianzani U; D'Alfonso S
Hum Immunol; 2011 Oct; 72(10):930-4. PubMed ID: 21763380
[TBL] [Abstract][Full Text] [Related]
18. The autoimmune disease risk allele of UBE2L3 in African American patients with systemic lupus erythematosus: a recessive effect upon subphenotypes.
Agik S; Franek BS; Kumar AA; Kumabe M; Utset TO; Mikolaitis RA; Jolly M; Niewold TB
J Rheumatol; 2012 Jan; 39(1):73-8. PubMed ID: 22045845
[TBL] [Abstract][Full Text] [Related]
19. The role of osteopontin as a candidate biomarker of renal involvement in systemic lupus erythematosus.
Spinelli FR; Garufi C; Truglia S; Pacucci VA; Morello F; Miranda F; Perricone C; Ceccarelli F; Valesini G; Conti F
Clin Exp Rheumatol; 2019; 37(6):899-905. PubMed ID: 31074728
[TBL] [Abstract][Full Text] [Related]
20. Type I interferon and T helper 17 cells co-exist and co-regulate disease pathogenesis in lupus patients.
Biswas PS; Aggarwal R; Levesque MC; Maers K; Ramani K
Int J Rheum Dis; 2015 Jul; 18(6):646-53. PubMed ID: 25960196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
